Ozempic before or after plastic surgery: what the evidence says

What did @drcarloscardenas actually say?

The audio in this video is heavily distorted and nearly unintelligible, so quoting it precisely is difficult. That transparency matters. Based on what can be parsed, the creator argues that semaglutide (Ozempic/Wegovy) should be used after plastic surgery, not before. The core reasoning appears to be threefold: GLP-1 agonists reduce nutrient absorption in ways that can impair wound healing, stopping them before surgery is safer, and using them too soon after a body contouring procedure like abdominoplasty risks accelerated weight loss that could leave excess skin and require revision surgery. The video also warns against stopping GLP-1 medications abruptly, and closes with a recommendation to consult a specialist before starting semaglutide.

These are real clinical concerns that plastic surgeons and obesity medicine physicians actively debate. The creator is not inventing controversy here.

Does the science back this up?

Mostly, yes, though the evidence base is still thin and the nuance gets lost in a short video. GLP-1 agonists are known to slow gastric emptying, which creates legitimate anesthesia risks perioperatively. On wound healing, the picture is more complicated than a simple "Ozempic impairs healing" framing.

The American Society of Anesthesiologists issued guidance in 2023 recommending that patients on GLP-1 agonists consider pausing them before elective procedures due to aspiration risk from delayed gastric emptying. That is a real, documented concern. On nutrition and wound healing, GLP-1 drugs do reduce caloric intake significantly, and caloric and protein deficits are established risk factors for poor wound healing (Stechmiller, 2010, Nutrition in Clinical Practice). However, no large randomized controlled trials have specifically studied semaglutide's effect on plastic surgery wound outcomes. The concern is logical but extrapolated, not proven in this specific population.

The "excess skin after weight loss requiring revision" argument is clinically sound. Rapid postoperative weight loss after a tummy tuck or similar procedure is a documented complication driver (Matarasso et al., 2006, Plastic and Reconstructive Surgery).

What did they get wrong (or right)?

Credit where it is due: the sequencing recommendation, use GLP-1 drugs after rather than before body contouring, is consistent with the emerging consensus among plastic surgeons who treat patients on these medications. The wound healing and nutrition concern is biologically plausible and clinically relevant.

What the video oversimplifies: the creator implies a universal rule when real guidance is individualized. A patient using semaglutide for type 2 diabetes management is in a different risk category than someone using it purely for cosmetic weight loss before a tuck. Stopping semaglutide abruptly in a diabetic patient before surgery carries its own risks that go unmentioned here.

The video also does not distinguish between different GLP-1 agents, doses, or surgery types. A rhinoplasty carries different wound healing demands than a full abdominoplasty. Lumping them together is a real oversimplification.

And the audio quality is so poor that any specific dosing or timing guidance, if it was given, could not be verified. That alone is a problem for a medical advice video.

What should you actually know?

If you are on a GLP-1 agonist and planning elective surgery, this is not a decision you should make based on a TikTok. Current anesthesia guidance (ASA, 2023) suggests discussing a pause in GLP-1 therapy with your prescriber and anesthesiologist before any elective procedure. The recommended pause period varies by drug and formulation.

On the sequencing question specifically: there is growing clinical agreement that stabilizing weight on a GLP-1 drug before body contouring gives surgeons a more predictable outcome target and reduces the risk of results being undone by continued rapid loss. A 2023 commentary in Aesthetic Surgery Journal (Rohrich et al.) recommended weight stabilization for at least three months before elective body contouring in patients on GLP-1 therapy.

Nutritional status before surgery is genuinely important. If you are losing weight rapidly on semaglutide or tirzepatide, your protein intake deserves attention before you go under general anesthesia. Talk to a registered dietitian, not just your surgeon.

• Do not stop a prescribed GLP-1 medication without talking to the prescribing physician first.
• If your GLP-1 is prescribed for diabetes, the calculus is different than if it is prescribed for weight loss alone.
• No compounded semaglutide product has the same clinical evidence base as FDA-approved branded formulations.